Emergent BioSolutions Inc. SEC filings EBS
Emergent BioSolutions Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 29, 2014. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Apr 30, 2026 | — |
| S-3 | Shelf registration | Aug 7, 2025 | — |
| 424B3 | Prospectus | Mar 24, 2025 | — |
| POS AM | Filing | Mar 4, 2025 | — |
| 424B3 | Prospectus | Mar 4, 2025 | — |
| 424B3 | Prospectus | Dec 4, 2024 | — |
| S-1/A | Amended registration statement | Dec 2, 2024 | — |
| S-1 | Registration statement | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| S-8 POS | Filing | Dec 13, 2023 | — |
| S-8 | Employee stock plan registration | Dec 11, 2023 | — |
| S-8 | Employee stock plan registration | Jun 5, 2023 | — |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| S-3ASR | Automatic shelf registration | Aug 9, 2021 | — |
| S-8 | Employee stock plan registration | Jun 4, 2021 | — |
| S-3ASR | Automatic shelf registration | Aug 3, 2018 | — |
| S-8 | Employee stock plan registration | May 30, 2018 | — |
| S-8 | Employee stock plan registration | Feb 28, 2017 | — |
| S-3ASR | Automatic shelf registration | May 22, 2015 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EBS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- Accelerated filer
- SEC CIK
- 1367644
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.